ZNF507 activators encompass a range of chemical compounds that indirectly augment the functional activity of ZNF507 through their influence on cellular pathways and transcriptional regulation mechanisms. Phorbol 12-myristate 13-acetate (PMA) and Forskolin, for instance, act on the protein kinase C (PKC) and adenylate cyclase pathways respectively, both of which could lead to phosphorylation of transcription factors that interact with ZNF507, thus potentially enhancing its ability to regulate gene expression. Similarly, Ionomycin, by increasing intracellular calciumlevels, may activate calcium-dependent kinases and phosphatases that can modify transcriptional complexes and enhance ZNF507's activity. Trichostatin A and Sodium butyrate, both histone deacetylase inhibitors, and 5-Azacytidine, a DNA methylation inhibitor, work to make the chromatin structure more accessible, possibly improving ZNF507's transcriptional regulation of specific genes.
Further supporting ZNF507's role in gene regulation, Epigallocatechin gallate (EGCG) and Curcumin can modulate the activity of protein kinases and transcription factors that may normally compete with or regulate ZNF507's function, potentially allowing for greater ZNF507 activity. Resveratrol's activation of SIRT1 could similarly lead to deacetylation of transcription factors that associate with ZNF507, while Retinoic acid can affect gene expression through its receptor interactions, possibly influencing the transcriptional networks involving ZNF507. Lithium Chloride's inhibition of GSK-3 may stabilize transcription factors that synergize with ZNF507, thus enhancing its regulatory functions. Lastly, Spermidine promotes autophagy, which could degrade negative regulators of transcriptional complexes involving ZNF507, thereby indirectly enhancing its activity in the cell. These chemical activators, through their distinct biochemical actions, contribute to the potential upregulation of ZNF507's functional involvement in transcriptional regulation without directly influencing its expression level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol (DAG) analog and potent activator of protein kinase C (PKC), which can lead to the phosphorylation of various transcription factors. This could enhance ZNF507's activity by facilitating the phosphorylation of transcription factors that cooperate with ZNF507 in gene regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which subsequently activates PKA. PKA can phosphorylate transcription factors that may interact with ZNF507, thereby enhancing ZNF507’s transcriptional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, thereby activating calcium-dependent phosphatases and kinases. These enzymes can modify the transcriptional complex in which ZNF507 operates, enhancing its functional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that alters chromatin structure, which can increase the accessibility of the transcriptional machinery to DNA, potentially enhancing ZNF507's ability to regulate gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferase, leading to reduced DNA methylation, which could enhance ZNF507's target gene expression by making the chromatin more accessible for transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a known inhibitor of various protein kinases. By inhibiting kinases that negatively regulate transcription factors cooperating with ZNF507, EGCG could enhance ZNF507's transcriptional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to activate sirtuin 1 (SIRT1), a protein deacetylase. Activation of SIRT1 could modify transcription factors and co-regulators associated with ZNF507, potentially enhancing its transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, which can heterodimerize with other transcription factors and regulate gene expression. This could enhance ZNF507's functional activity by influencing transcriptional networks in which it participates. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 could lead to the stabilization and activation of transcription factors that synergize with ZNF507 in gene regulation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can alter chromatin structure, potentially enhancing the transcriptional regulation activity of ZNF507 by making chromatin more accessible. | ||||||